<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2025-334</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-9418</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЗАБОЛЕВАНИЯ КОЖИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DERMAL DISEASES</subject></subj-group></article-categories><title-group><article-title>Роль половых гормонов в развитии атопического дерматита у женщин</article-title><trans-title-group xml:lang="en"><trans-title>The role of sex hormones in the development of atopic dermatitis in women</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5537-5729</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кандрашкина</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kandrashkina</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандрашкина Юлия Андреевна - к.м.н., старший преподаватель.</p><p>440026, Пенза, ул. Красная, д. 40</p></bio><bio xml:lang="en"><p>Yulia A. Kandrashkina - Cand. Sci. (Med.), Senior Lecturer, Department of Obstetrics and Gynecology.</p><p>40, Krasnaya St., 440026, Penza</p></bio><email xlink:type="simple">novikova10l@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3902-2018</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орлова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Orlova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Орлова Екатерина Александровна - д.м.н., доцент, заведующая кафедрой аллергологии и иммунологии с курсом дерматовенерологии и косметологии.</p><p>440060, Пенза, ул. Стасова, д. 8а</p></bio><bio xml:lang="en"><p>Ekaterina A. Orlova - Dr. Sci. (Med.), Associate Professor, Head of Department of Allergology and Immunology with a Course of Dermatovenereology and Cosmetology.</p><p>8a, Stasov St., 440060, Penza</p></bio><email xlink:type="simple">lisaorl@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Пензенский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Penza State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Пензенский институт усовершенствования врачей – филиал Российской медицинской академии непрерывного медицинского образования</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Penza Institute for Advanced Medical Education – a branch of the Russian Medical Academy of Continuing Medical Education</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>30</day><month>09</month><year>2025</year></pub-date><volume>0</volume><issue>14</issue><fpage>146</fpage><lpage>151</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кандрашкина Ю.А., Орлова Е.А., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Кандрашкина Ю.А., Орлова Е.А.</copyright-holder><copyright-holder xml:lang="en">Kandrashkina Y.A., Orlova E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/9418">https://www.med-sovet.pro/jour/article/view/9418</self-uri><abstract><p>Атопический дерматит (АтД) представляет собой хроническое воспалительное заболевание кожи, широко распространенное во всем мире. У женщин заболевание встречается чаще, чем у мужчин. Данное различие можно объяснить с позиции влияния половых гормонов на функционирование кожного барьера и иммунной системы. Колебания концентрации половых гормонов коррелируют с частотой возникновения АтД. Во время лютеиновой фазы менструального цикла чаще отмечается развитие обострения АтД или ухудшение течения данного заболевания, что связано с выработкой прогестерона и эстрогенов, а в фолликулярную фазу – улучшение течения АтД, что обусловлено преимущественным действием эстрогенов. В течение менструального цикла у женщин происходит изменение барьерной функции кожи, характеризующееся сухостью, нарушением чувствительности и повышением трансэпидермальной потери воды, что свидетельствует о выраженном влиянии половых гормонов на кожу. Половые гормоны могут стимулировать выработку ряда цитокинов, принимающих участие в формировании кожного воспалительного процесса, а также кожного зуда. В период беременности иммунная система модифицируется до достижения иммунной толерантности, эти изменения происходят как на уровне «мать – плод», так и в системном кровотоке, что обусловлено в первую очередь увеличением концентрации прогестерона во время беременности. Изменение гормонального фона при беременности смещает баланс в иммунной системе, что может быть пусковым моментом для развития АтД. Изучение гормонального статуса при обострении АтД, в т. ч. и при беременности, является перспективным и может способствовать разработке профилактических и лечебных мероприятий.</p></abstract><trans-abstract xml:lang="en"><p>Atopic dermatitis (AD) is a chronic inflammatory skin disease that is widespread throughout the world. The disease is more common in women than in men. This difference can be explained by the influence of sex hormones on the functioning of the skin barrier and the immune system. Fluctuations in the concentration of sex hormones correlate with the incidence of AD. During the luteal phase of the menstrual cycle, AD exacerbation or worsening of the disease is more common, which is associated with the production of progesterone and estrogens, and during the follicular phase, AD improves due to the predominant effect of estrogens. During the menstrual cycle, women experience a change in the barrier function of the skin, characterized by dryness, impaired sensitivity, and increased transepidermal water loss, which indicates a pronounced effect of sex hormones on the skin. Sex hormones can stimulate the production of a number of cytokines involved in the formation of skin inflammation and itching. During pregnancy, the immune system is modified to achieve immune tolerance; these changes occur both at the mother-fetus level and in the systemic bloodstream, primarily due to an increase in progesterone concentration during pregnancy. Changes in hormonal levels during pregnancy shift the balance in the immune system, which can be a trigger for the development of AD. Studying hormonal status during AD exacerbation, including during pregnancy, is promising and can contribute to the development of preventive and therapeutic measures.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>атопический дерматит</kwd><kwd>эстрогены</kwd><kwd>андрогены</kwd><kwd>прогестерон</kwd><kwd>кожный барьер</kwd><kwd>цитокины</kwd><kwd>беременность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>atopic dermatitis</kwd><kwd>estrogens</kwd><kwd>androgens</kwd><kwd>progesterone</kwd><kwd>skin barrier</kwd><kwd>cytokines</kwd><kwd>pregnancy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Furue M, Chiba T, Tsuji G, Ulzii D, Kido-Nakahara M, Nakahara T, Kadono T. Atopic dermatitis: Immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergol Int. 2017;66(3):398–403. https://doi.org/10.1016/j.alit.2016.12.002.</mixed-citation><mixed-citation xml:lang="en">Furue M, Chiba T, Tsuji G, Ulzii D, Kido-Nakahara M, Nakahara T, Kadono T. Atopic dermatitis: Immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergol Int. 2017;66(3):398–403. https://doi.org/10.1016/j.alit.2016.12.002.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Egawa G, Kabashima K. Barrier dysfunction in the skin allergy. Allergol Int. 2018;67(1):3–11. https://doi.org/10.1016/j.alit.2017.10.002.</mixed-citation><mixed-citation xml:lang="en">Egawa G, Kabashima K. Barrier dysfunction in the skin allergy. Allergol Int. 2018;67(1):3–11. https://doi.org/10.1016/j.alit.2017.10.002.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(1):8–16. https://doi.org/10.1159/000370220.</mixed-citation><mixed-citation xml:lang="en">Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(1):8–16. https://doi.org/10.1159/000370220.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Eichenfield LF, Stripling S, Fung S, Cha A, O’Brien A, Schachner LA. Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting. Paediatr Drugs. 2022;24(4):293–305. https://doi.org/10.1007/s40272-022-00499-x.</mixed-citation><mixed-citation xml:lang="en">Eichenfield LF, Stripling S, Fung S, Cha A, O’Brien A, Schachner LA. Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting. Paediatr Drugs. 2022;24(4):293–305. https://doi.org/10.1007/s40272-022-00499-x.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ненашева НМ. Современная терапия атопического дерматита: роль эмолентов и антигистаминных препаратов. Эффективная фармакотерапия. Аллергология и иммунология. 2016;1(6):6–14. Режим доступа: https://umedp.ru/upload/iblock/e5c/zodak.pdf.</mixed-citation><mixed-citation xml:lang="en">Nenasheva NM. Modern therapy of atopic dermatitis: the role of emollients and antihistamines. Effective Pharmacotherapy. Allergology and Immunology. 2016;1(6):6–14. (In Russ.) Available at: https://umedp.ru/upload/iblock/e5c/zodak.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Flohr C, England K, Radulovic S, McLean WH, Campbel LE, Barker J et al. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age. Br J Dermatol. 2010;163(6):1333–1336. https://doi.org/10.1111/j.13652133.2010.10068.x.</mixed-citation><mixed-citation xml:lang="en">Flohr C, England K, Radulovic S, McLean WH, Campbel LE, Barker J et al. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age. Br J Dermatol. 2010;163(6):1333–1336. https://doi.org/10.1111/j.13652133.2010.10068.x.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kobiela A, Hovhannisyan L, Jurkowska P, de la Serna JB, Bogucka A, Deptuła M et al. Excess filaggrin in keratinocytes is removed by extracellular vesicles to prevent premature death and this mechanism can be hijacked by Staphylococcus aureus in a TLR2-dependent fashion. J Extracell Vesicles. 2023;12(6):e12335. https://doi.org/10.1002/jev2.12335.</mixed-citation><mixed-citation xml:lang="en">Kobiela A, Hovhannisyan L, Jurkowska P, de la Serna JB, Bogucka A, Deptuła M et al. Excess filaggrin in keratinocytes is removed by extracellular vesicles to prevent premature death and this mechanism can be hijacked by Staphylococcus aureus in a TLR2-dependent fashion. J Extracell Vesicles. 2023;12(6):e12335. https://doi.org/10.1002/jev2.12335.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Presland RB, Kuechle MK, Lewis SP, Fleckman P, Dale BA. Regulated expression of human filaggrin in keratinocytes results in cytoskeletal disruption, loss of cell-cell adhesion, and cell cycle arrest. Exp Cell Res. 2001;270(2):199–213. https://doi.org/10.1006/excr.2001.5348.</mixed-citation><mixed-citation xml:lang="en">Presland RB, Kuechle MK, Lewis SP, Fleckman P, Dale BA. Regulated expression of human filaggrin in keratinocytes results in cytoskeletal disruption, loss of cell-cell adhesion, and cell cycle arrest. Exp Cell Res. 2001;270(2):199–213. https://doi.org/10.1006/excr.2001.5348.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Yuki T, Tobiishi M, Kusaka-Kikushima A, Ota Y, Tokura Y. Impaired tight junctions in atopic dermatitis skin and in a skin-equivalent model treated with interleukin-17. PLoS ONE. 2016;11:e0161759. https://doi.org/10.1371/journal.pone.0161759.</mixed-citation><mixed-citation xml:lang="en">Yuki T, Tobiishi M, Kusaka-Kikushima A, Ota Y, Tokura Y. Impaired tight junctions in atopic dermatitis skin and in a skin-equivalent model treated with interleukin-17. PLoS ONE. 2016;11:e0161759. https://doi.org/10.1371/journal.pone.0161759.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nomura T, Honda T, Kabashima K. Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers. Int Immunol. 2018;30:419–428. https://doi.org/10.1093/intimm/dxy015.</mixed-citation><mixed-citation xml:lang="en">Nomura T, Honda T, Kabashima K. Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers. Int Immunol. 2018;30:419–428. https://doi.org/10.1093/intimm/dxy015.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kanda N, Hoashi T, Saeki H. The Roles of Sex Hormones in the Course of Atopic Dermatitis. Int J Mol Sci. 2019;20(19):4660. https://doi.org/10.3390/ijms20194660.</mixed-citation><mixed-citation xml:lang="en">Kanda N, Hoashi T, Saeki H. The Roles of Sex Hormones in the Course of Atopic Dermatitis. Int J Mol Sci. 2019;20(19):4660. https://doi.org/10.3390/ijms20194660.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Farage MA, Neill S, MacLean AB. Physiological changes associated with the menstrual cycle: A review. Obstet Gynecol Surv. 2009;64(1):58–72. https://doi.org/10.1097/OGX.0b013e3181932a37.</mixed-citation><mixed-citation xml:lang="en">Farage MA, Neill S, MacLean AB. Physiological changes associated with the menstrual cycle: A review. Obstet Gynecol Surv. 2009;64(1):58–72. https://doi.org/10.1097/OGX.0b013e3181932a37.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Raghunath RS, Venables ZC, Millington GW. The menstrual cycle and the skin. Clin Exp Dermatol. 2015;40(2):111–115. https://doi.org/10.1111/ced.12588.</mixed-citation><mixed-citation xml:lang="en">Raghunath RS, Venables ZC, Millington GW. The menstrual cycle and the skin. Clin Exp Dermatol. 2015;40(2):111–115. https://doi.org/10.1111/ced.12588.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kiriyama K, Sugiura H, ·Uehara M. Premenstrual deterioration of skin symptoms in female patients with atopic dermatitis. Dermatology. 2003;206(2):110–112. https://doi.org/10.1159/000068463.</mixed-citation><mixed-citation xml:lang="en">Kiriyama K, Sugiura H, ·Uehara M. Premenstrual deterioration of skin symptoms in female patients with atopic dermatitis. Dermatology. 2003;206(2):110–112. https://doi.org/10.1159/000068463.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Farage MA, Berardesca E, Maibach H. The possible relevance of sex hormones on irritant and allergic responses: their importance for skin testing. Contact Dermatitis. 2010;62(2):67–74. https://doi.org/10.1111/j.16000536.2009.01621.x.</mixed-citation><mixed-citation xml:lang="en">Farage MA, Berardesca E, Maibach H. The possible relevance of sex hormones on irritant and allergic responses: their importance for skin testing. Contact Dermatitis. 2010;62(2):67–74. https://doi.org/10.1111/j.16000536.2009.01621.x.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bonamonte D, Foti C, Antelmi AR, Biscozzi AM, Naro ED, Fanelli M et al. Nickel contact allergy and menstrual cycle. Contact Dermatitis. 2005;52(6):309–313. https://doi.org/10.1111/j.0105-1873.2005.00588.x.</mixed-citation><mixed-citation xml:lang="en">Bonamonte D, Foti C, Antelmi AR, Biscozzi AM, Naro ED, Fanelli M et al. Nickel contact allergy and menstrual cycle. Contact Dermatitis. 2005;52(6):309–313. https://doi.org/10.1111/j.0105-1873.2005.00588.x.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Balakirski G, Novak N. Atopic dermatitis and pregnancy. J Allergy Clin Immunol. 2022;149(4):1185–1194. https://doi.org/10.1016/j.jaci.2022.01.010.</mixed-citation><mixed-citation xml:lang="en">Balakirski G, Novak N. Atopic dermatitis and pregnancy. J Allergy Clin Immunol. 2022;149(4):1185–1194. https://doi.org/10.1016/j.jaci.2022.01.010.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tai P, Wang J, Jin H, Song X, Yan J, Kang Y et al. Induction of regulatory T cells by physiological level estrogen. J Cell Physiol. 2008;214(2):456–464. https://doi.org/10.1002/jcp.21221.</mixed-citation><mixed-citation xml:lang="en">Tai P, Wang J, Jin H, Song X, Yan J, Kang Y et al. Induction of regulatory T cells by physiological level estrogen. J Cell Physiol. 2008;214(2):456–464. https://doi.org/10.1002/jcp.21221.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Miyaura H, Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol. 2002;168(3):1087–1094. https://doi.org/10.4049/jimmunol.168.3.1087.</mixed-citation><mixed-citation xml:lang="en">Miyaura H, Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol. 2002;168(3):1087–1094. https://doi.org/10.4049/jimmunol.168.3.1087.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kissick HT, Sanda MG, Dunn LK, Pellegrini KL, On ST, Noel JK, Arredouani MS. Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation. Proc Natl Acad Sci U S A. 2014;111(27):9887–9892. https://doi.org/10.1073/pnas.1402468111.</mixed-citation><mixed-citation xml:lang="en">Kissick HT, Sanda MG, Dunn LK, Pellegrini KL, On ST, Noel JK, Arredouani MS. Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation. Proc Natl Acad Sci U S A. 2014;111(27):9887–9892. https://doi.org/10.1073/pnas.1402468111.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hepworth MR, Hardman MJ, Grencis RK. The role of sex hormones in the development of Th2 immunity in a gender-biased model of Trichuris muris infection. Eur J Immunol. 2010;40(2):406–416. https://doi.org/10.1002/eji.200939589.</mixed-citation><mixed-citation xml:lang="en">Hepworth MR, Hardman MJ, Grencis RK. The role of sex hormones in the development of Th2 immunity in a gender-biased model of Trichuris muris infection. Eur J Immunol. 2010;40(2):406–416. https://doi.org/10.1002/eji.200939589.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Trigunaite A, Dimo J, Jørgensen TN. Suppressive effects of androgens on the immune system. Cell Immunol. 2015;294(2):87–94. https://doi.org/10.1016/j.cellimm.2015.02.004.</mixed-citation><mixed-citation xml:lang="en">Trigunaite A, Dimo J, Jørgensen TN. Suppressive effects of androgens on the immune system. Cell Immunol. 2015;294(2):87–94. https://doi.org/10.1016/j.cellimm.2015.02.004.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Fuseini H, Yung JA, Cephus JY, Zhang J, Goleniewska K, Polosukhin VV et al. Testosterone Decreases House Dust Mite-Induced Type 2 and IL-17AMediated Airway Inflammation. J Immunol. 2018;201(7):1843–1854. https://doi.org/10.4049/jimmunol.1800293.</mixed-citation><mixed-citation xml:lang="en">Fuseini H, Yung JA, Cephus JY, Zhang J, Goleniewska K, Polosukhin VV et al. Testosterone Decreases House Dust Mite-Induced Type 2 and IL-17AMediated Airway Inflammation. J Immunol. 2018;201(7):1843–1854. https://doi.org/10.4049/jimmunol.1800293.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Massa MG, David C, Jörg S, Berg J, Gisevius B, Hirschberg S et al. Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration. Am J Pathol. 2017;187(7):1613–1622. https://doi.org/10.1016/j.ajpath.2017.03.006.</mixed-citation><mixed-citation xml:lang="en">Massa MG, David C, Jörg S, Berg J, Gisevius B, Hirschberg S et al. Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration. Am J Pathol. 2017;187(7):1613–1622. https://doi.org/10.1016/j.ajpath.2017.03.006.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Walecki M, Eisel F, Klug J, Baal N, Paradowska-Dogan A, Wahle E et al. Androgen receptor modulates Foxp3 expression in CD4+CD25+Foxp3+ regulatory T-cells. Mol Biol Cell. 2015;26(15):2845–2857. https://doi.org/10.1091/mbc.E14-08-1323.</mixed-citation><mixed-citation xml:lang="en">Walecki M, Eisel F, Klug J, Baal N, Paradowska-Dogan A, Wahle E et al. Androgen receptor modulates Foxp3 expression in CD4+CD25+Foxp3+ regulatory T-cells. Mol Biol Cell. 2015;26(15):2845–2857. https://doi.org/10.1091/mbc.E14-08-1323.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Dayoub O, Le Lay S, Soleti R, Clere N, Hilairet G, Dubois S et al. Estrogen receptor α/HDAC/NFAT axis for delphinidin effects on proliferation and differentiation of T lymphocytes from patients with cardiovascular risks. Sci Rep. 2017;7(1):9378. https://doi.org/10.1038/s41598-017-09933-4.</mixed-citation><mixed-citation xml:lang="en">Dayoub O, Le Lay S, Soleti R, Clere N, Hilairet G, Dubois S et al. Estrogen receptor α/HDAC/NFAT axis for delphinidin effects on proliferation and differentiation of T lymphocytes from patients with cardiovascular risks. Sci Rep. 2017;7(1):9378. https://doi.org/10.1038/s41598-017-09933-4.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Matalka KZ. The effect of estradiol, but not progesterone, on the production of cytokines in stimulated whole blood, is concentration-dependent. Neuro Endocrinol Lett. 2003;24(3-4):185–191. Available at: https://pubmed.ncbi.nlm.nih.gov/14523355.</mixed-citation><mixed-citation xml:lang="en">Matalka KZ. The effect of estradiol, but not progesterone, on the production of cytokines in stimulated whole blood, is concentration-dependent. Neuro Endocrinol Lett. 2003;24(3-4):185–191. Available at: https://pubmed.ncbi.nlm.nih.gov/14523355.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Watanabe Y, Tajiki-Nishino R, Tajima H, Fukuyama T. Role of estrogen receptors α and β in the development of allergic airway inflammation in mice: A possible involvement of interleukin 33 and eosinophils. Toxicology. 2019;411:93–100. https://doi.org/10.1016/j.tox.2018.11.002.</mixed-citation><mixed-citation xml:lang="en">Watanabe Y, Tajiki-Nishino R, Tajima H, Fukuyama T. Role of estrogen receptors α and β in the development of allergic airway inflammation in mice: A possible involvement of interleukin 33 and eosinophils. Toxicology. 2019;411:93–100. https://doi.org/10.1016/j.tox.2018.11.002.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lorenz TK, Heiman JR, Demas GE. Sexual activity modulates shifts in TH1/TH2 cytokine profile across the menstrual cycle: an observational study. Fertil Steril. 2015;104(6):1513–21.e214. https://doi.org/10.1016/j.fertnstert.2015.09.001.</mixed-citation><mixed-citation xml:lang="en">Lorenz TK, Heiman JR, Demas GE. Sexual activity modulates shifts in TH1/TH2 cytokine profile across the menstrual cycle: an observational study. Fertil Steril. 2015;104(6):1513–21.e214. https://doi.org/10.1016/j.fertnstert.2015.09.001.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Hall OJ, Limjunyawong N, Vermillion MS, Robinson DP, Wohlgemuth N, Pekosz A. Progesterone-Based Therapy Protects Against Influenza by Promoting Lung Repair and Recovery in Females. PLoS Pathogens. 2016;12(9):e1005840. https://doi.org/10.1371/journal.ppat.1005840.</mixed-citation><mixed-citation xml:lang="en">Hall OJ, Limjunyawong N, Vermillion MS, Robinson DP, Wohlgemuth N, Pekosz A. Progesterone-Based Therapy Protects Against Influenza by Promoting Lung Repair and Recovery in Females. PLoS Pathogens. 2016;12(9):e1005840. https://doi.org/10.1371/journal.ppat.1005840.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Sulcová J, Hill M, Hampl R, Stárka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol. 1997;154(1):57–62. https://doi.org/10.1677/joe.0.1540057.</mixed-citation><mixed-citation xml:lang="en">Sulcová J, Hill M, Hampl R, Stárka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol. 1997;154(1):57–62. https://doi.org/10.1677/joe.0.1540057.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Firooz A, Sadr B, Babakoohi S, Sarraf-Yazdy M, Fanian F, Kazerouni-Timsar A, Nassiri-Kashani M et al. Variation of biophysical parameters of the skin with age, gender, and body region. Sci World J. 2012;2012:386936. https://doi.org/10.1100/2012/386936.</mixed-citation><mixed-citation xml:lang="en">Firooz A, Sadr B, Babakoohi S, Sarraf-Yazdy M, Fanian F, Kazerouni-Timsar A, Nassiri-Kashani M et al. Variation of biophysical parameters of the skin with age, gender, and body region. Sci World J. 2012;2012:386936. https://doi.org/10.1100/2012/386936.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y, Yokozeki H, Katagiri K. Physiological and functional changes in the stratum corneum restored by oestrogen in an ovariectomized mice model of climacterium. Exp Dermatol. 2017;26(5):394–401. https://doi.org/10.1111/exd.13214.</mixed-citation><mixed-citation xml:lang="en">Chen Y, Yokozeki H, Katagiri K. Physiological and functional changes in the stratum corneum restored by oestrogen in an ovariectomized mice model of climacterium. Exp Dermatol. 2017;26(5):394–401. https://doi.org/10.1111/exd.13214.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kao JS, Garg A, Mao-Qiang M, Crumrine D, Ghadially R, Feingold KR, Elias PM. Testosterone perturbs epidermal permeability barrier homeostasis. J Invest Dermatol. 2001;116(3):443–451. https://doi.org/10.1046/j.15231747.2001.01281.x.</mixed-citation><mixed-citation xml:lang="en">Kao JS, Garg A, Mao-Qiang M, Crumrine D, Ghadially R, Feingold KR, Elias PM. Testosterone perturbs epidermal permeability barrier homeostasis. J Invest Dermatol. 2001;116(3):443–451. https://doi.org/10.1046/j.15231747.2001.01281.x.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Tsutsumi M, Denda M. Paradoxical effects of beta-estradiol on epidermal permeability barrier homeostasis. Br J Dermatol. 2007;157(4):776–779. https://doi.org/10.1111/j.1365-2133.2007.08115.x.</mixed-citation><mixed-citation xml:lang="en">Tsutsumi M, Denda M. Paradoxical effects of beta-estradiol on epidermal permeability barrier homeostasis. Br J Dermatol. 2007;157(4):776–779. https://doi.org/10.1111/j.1365-2133.2007.08115.x.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Yosipovitch G, Rosen JD, Hashimoto T. Itch: From mechanism to (novel) therapeutic approaches. J Allergy Clin Immunol. 2018;142(5):1375–1390. https://doi.org/10.1016/j.jaci.2018.09.005.</mixed-citation><mixed-citation xml:lang="en">Yosipovitch G, Rosen JD, Hashimoto T. Itch: From mechanism to (novel) therapeutic approaches. J Allergy Clin Immunol. 2018;142(5):1375–1390. https://doi.org/10.1016/j.jaci.2018.09.005.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Ambros-Rudolph CM, Müllegger RR, Vaughan-Jones SA, Kerl H, Black MM. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol. 2006;54(3):395–404. https://doi.org/10.1016/j.jaad.2005.12.012.</mixed-citation><mixed-citation xml:lang="en">Ambros-Rudolph CM, Müllegger RR, Vaughan-Jones SA, Kerl H, Black MM. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol. 2006;54(3):395–404. https://doi.org/10.1016/j.jaad.2005.12.012.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Zen M, Ghirardello A, Iaccarino L, Tonon M, Campana C, Arienti S et al. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly. 2010;140(13-14):187–201. https://doi.org/10.4414/smw.2010.12597.</mixed-citation><mixed-citation xml:lang="en">Zen M, Ghirardello A, Iaccarino L, Tonon M, Campana C, Arienti S et al. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly. 2010;140(13-14):187–201. https://doi.org/10.4414/smw.2010.12597.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Хамдамов БЗ, Турдыева ДО, Рустамова НБ. Синтез цитокинов при физиологически протекающей беременности. Российский иммунологический журнал. 2024;27(4):853–858. https://doi.org/10.46235/1028-7221-16954-SOC.</mixed-citation><mixed-citation xml:lang="en">Khamdamov BZ, Turdyeva DO, Rustamova NB. Synthesis of cytokines during physiological pregnancy. Russian Journal of Immunology. 2024;27(4):853–858 (In Russ.) https://doi.org/10.46235/1028-7221-16954-SOC.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Альбанова ВИ, Петрова CЮ. Особенности ведения атопического дерматита у беременных. Вестник дерматологии и венерологии. 2023;99(5):29–40. https://doi.org/10.25208/vdv13279.</mixed-citation><mixed-citation xml:lang="en">Albanova VI, Petrova SY. Features of management of atopic dermatitis in pregnant women. Vestnik Dermatologii i Venerologii. 2023;99(5):29–40. (In Russ.) https://doi.org/10.25208/vdv13279.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Mulac-Jericevic B, Conneely OM. Reproductive tissue selective actions of progesterone receptors. Reproduction. 2004;128(2):139–146. https://doi.org/10.1530/rep.1.00189.</mixed-citation><mixed-citation xml:lang="en">Mulac-Jericevic B, Conneely OM. Reproductive tissue selective actions of progesterone receptors. Reproduction. 2004;128(2):139–146. https://doi.org/10.1530/rep.1.00189.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science. 2000;289(5485):1751–1754. https://doi.org/10.1126/science.289.5485.1751.</mixed-citation><mixed-citation xml:lang="en">Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science. 2000;289(5485):1751–1754. https://doi.org/10.1126/science.289.5485.1751.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Arruvito L, Giulianelli S, Flores AC, Paladino N, Barboza M, Lanari C, Fainboim L. NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J Immunol. 2008;180(8):5746–5753. https://doi.org/10.4049/jimmunol.180.8.5746.</mixed-citation><mixed-citation xml:lang="en">Arruvito L, Giulianelli S, Flores AC, Paladino N, Barboza M, Lanari C, Fainboim L. NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J Immunol. 2008;180(8):5746–5753. https://doi.org/10.4049/jimmunol.180.8.5746.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Szekeres-Bartho J, Schindler AE. Progestogens and immunology. Best Pract Res Clin Obstet Gynaecol. 2019;60:17–23. https://doi.org/10.1016/j.bpobgyn.2019.07.001.</mixed-citation><mixed-citation xml:lang="en">Szekeres-Bartho J, Schindler AE. Progestogens and immunology. Best Pract Res Clin Obstet Gynaecol. 2019;60:17–23. https://doi.org/10.1016/j.bpobgyn.2019.07.001.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Зайдиева ЗС, Прозоров ВВ, Карапетян ТЭ. Прогестероновая поддержка при планировании беременности у женщин с высоким инфекционным риском. РМЖ. 2006;(1):25. Режим доступа: https://www.rmj.ru/articles/obshchie-stati/Progesteronovaya_podderghka_pri_planirovanii_beremennosti_u_ghenschin_s_vysokim_infekcionnym_riskom.</mixed-citation><mixed-citation xml:lang="en">Zajdieva ZS, Prozorov VV, Karapetyan TE. Progesterone support for pregnancy planning in women at high risk of infection. RMJ. 2006;(1):25. (In Russ.) Available at: https://www.rmj.ru/articles/obshchie-stati/Progesteronovaya_podderghka_pri_planirovanii_beremennosti_u_ghenschin_s_vysokim_infekcionnym_riskom.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
